Tredegar Corporation TG
5.69 USD -0.04 (-0.70%)
At closeNov 12, 2026, 5:05 PM EST
5.69 0.00 0.00%
After hours · Nov 12, 5:05 PM ET
5.58 Day range 5.76
5.26 52-week range 10.53
- YTD
- -20.75%
- 1 year
- -32.10%
News
zacks.com TG Stock Tumbles 19% As It Incurs Q3 Loss on Soft Construction Demand Tredegar's Q3 earnings per share turn negative due to lower aluminum shipments, weak films demand and higher input costs, while growing TSLOTS shipments and expected restructuring benefits offer…
gurufocus.com Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results on two of the RNA interference (RNAi) based therapies in its cardiometabolic pipeline at
benzinga.com Tredegar Q3 Adj. EPS $(0.04) Down From $0.26 YoY, Sales $177.270M Up From $162.470M YoY Tredegar (NYSE:TG) reported quarterly losses of $(0.04) per share. This is a 115.38 percent decrease over earnings of $0.26 per share from the same period last year. The company reported $177.270…
businesswire.com Tredegar Reports Third Quarter 2026 Results RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported third quarter financial results for the period ended September 30, 2026. CEO Commentary…
businesswire.com Tredegar Plans to Release Third Quarter 2026 Financial Results on November 6, 2026 RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG) plans to release financial results for the third quarter of 2026 on November 6, 2026. About Tredegar Tredegar Corporation is an…
zacks.com 2 Stocks That May Benefit from Data Center Build-out TG and MCEM may benefit from data center construction.
businesswire.com Tredegar Appoints Cindy Yao as Vice President, Chief Financial Officer and Treasurer RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Appoints Cindy Yao as Chief Financial Officer.
gurufocus.com Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia [url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, the company's
businesswire.com Tredegar Announces Departure of Kevin Donnelly, Executive Vice President, General Counsel and Corporate Secretary RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG) today announced that Kevin C. Donnelly, Executive Vice President, General Counsel and Corporate Secretary, will resign from the Company,…
businesswire.com Tredegar Provides Update on One Tredegar Transformation RICHMOND, Va.--(BUSINESS WIRE)--One Tredegar Transformation Update.
defenseworld.net BlackRock Inc. Purchases New Position in Tredegar Corporation $TG BlackRock Inc. purchased a new stake in Tredegar Corporation (NYSE: TG) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
defenseworld.net Connor Clark & Lunn Investment Management Ltd. Buys New Position in Tredegar Corporation $TG Connor Clark and Lunn Investment Management Ltd. bought a new stake in Tredegar Corporation (NYSE: TG) during the undefined quarter, according to the company in its most recent 13F filing with the…
gurufocus.com Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever
businesswire.com Tredegar Announces Election of Ana Dutra to Board of Directors RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES ELECTION OF ANA DUTRA TO BOARD OF DIRECTORS.
zacks.com Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains TG's Q2 earnings per share and sales improve year over year as Aluminum Extrusions benefit from favorable metal dynamics and rising TSLOTS demand, offsetting softer volumes and weaker High…
defenseworld.net Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why Tredegar Corporation (NYSE: TG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $8.29 and traded as high…
benzinga.com Tredegar Q2 Adj. EPS $0.18 Up From $0.05 YoY, Sales $209.764M Up From $172.963M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.18 per share. This is a 260 percent increase over earnings of $0.05 per share from the same period last year. The company reported $209.764…
businesswire.com Tredegar Reports Second Quarter 2026 Results RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS.
businesswire.com Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026 RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR PLANS TO RELEASE SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 7, 2026.- benzinga.com Tredegar's CFO Frasier W. Brickhouse II To Retire Effective On September 1, 2026 Tredegar Corporation (NYSE:TG) today announced that Frasier W. Brickhouse II, Tredegar’s Chief Financial Officer, Treasurer and Vice President, will retire, effective September 1, 2026.Tredegar’s…
businesswire.com Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026 RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES THE RETIREMENT OF FRASIER W. BRICKHOUSE II, CHIEF FINANCIAL OFFICER, TREASURER AND VICE PRESIDENT, EFFECTIVE SEPTEMBER 1, 2026.
gurufocus.com Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia [url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of pl
benzinga.com 10 Stocks That Prove Good Beats Perfect There is a line from Epictetus that I have thought about more times than I can count over thirty years of doing this work. He said, “Make the best use of what is in your power, and take the rest as…
gurufocus.com TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG) [url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZAÂ (olezarsen) a
benzinga.com Tredegar Q1 Adj. EPS $0.15 Up From $0.10 YoY, Sales $159.457M Up From $133.635M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.15 per share. This is a 50 percent increase over earnings of $0.10 per share from the same period last year. The company reported $159.457 million…
benzinga.com Tredegar Q4 Adj. EPS $0.32 Up From $0.06 YoY, Sales $154.505M Up From $122.462M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.32 per share. This is a 433.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $154.505…
benzinga.com Earnings Scheduled For March 11, 2026 - benzinga.com Tredegar's CEO John M. Steitz To Retire Effective December 31, 2025; Arijit (Bapi) DasGupta Elected Named CEO Effective January 1, 2026 Tredegar Corporation (NYSE:TG) today announced the retirement of John M. Steitz as its President and Chief Executive Officer and as a member of its Board of Directors (Board), effective December 31,…
- benzinga.com Tredegar Q3 Adj. EPS $0.26 Up From $0.01 YoY, Sales $162.470M Up From $115.717M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.26 per share. This is a 2500 percent increase over earnings of $0.01 per share from the same period last year. The company reported $162.470…
- benzinga.com Tredegar CFO D. Andrew Edwards To Retire, Effective Dec. 31 RICHMOND, Va.--(BUSINESS WIRE)-- Tredegar Corporation (NYSE:TG) today announced that D. Andrew Edwards, Tredegar's Chief Financial Officer and Executive Vice President, will retire, effective…
benzinga.com 12 Materials Stocks Moving In Thursday's After-Market Session 
benzinga.com Tredegar Q2 Adj. EPS $0.05 Down From $0.30 YoY, Sales $172.963M Down From $190.235M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.05 per share. This is a 83.33 percent decrease over earnings of $0.30 per share from the same period last- benzinga.com Tredegar Q1 Adj. EPS $0.10 Down From $0.14 YoY, Sales $133.63M Up From $114.22M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.10 per share. This is a 28.57 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $133.63…
- benzinga.com Tredegar Q4 Adj EPS $0.06 Up From $0.03 YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.06 per share. This is a 100 percent increase over earnings of $0.03 per share from the same period last year.
benzinga.com This Traeger Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday 
benzinga.com Tesla, Robinhood And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket 
benzinga.com Tredegar Surface Protection Launches Innovative Obsidian Automotive Protective Films, Designed To Meet The Evolving Needs Of The Automotive Industry Tredegar Surface Protection, a subsidiary of Tredegar Corporation (NYSE:TG) and a leader in high-quality masking films, is excited to announce the launch of Obsidian Automotive Protective Films.…
benzinga.com Tredegar Q2 Adj $0.30 Up From $(0.06) YoY, Sales $190.24M Up From $178.17M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.30 per share. This is a 600 percent increase over losses of $(0.06) per share from the same period last year. The company reported $190.24 million…- benzinga.com Top 3 Materials Stocks That Are Set To Fly This Quarter
benzinga.com ABAT Ramps Up Nevada Facility; US Gold Receives CK Gold Permit; Tredegar Terphane Sale Under Review And More: Thursday's Top Mining Stories ABAT Ramps Up Nevada Facility; U.S. Gold Receives CK Gold Permit; Tredegar Terphane Sale Under Review And More: Thursday's Top Mining Stories- benzinga.com Piedmont Lithium's Record Quarter For Production; Coal Prices Weigh On Rameco; Royal Gold Boosts Liquidity And More: Thursday's Top Mining Stories Piedmont Lithium's Record Quarter; Coal Prices Weigh On Rameco; Royal Gold Boosts Liquidity And More: Thursday's Top Mining StoriePiedmont Lithium reported record Q1 results with 40,439 dmt…
- benzinga.com CORRECTION: Tredegar Q1 Adj. EPS $0.16 Up From $0.07 YoY, Sales $175.74M Down From $191.12M YoY Tredegar (NYSE:TG) reported quarterly earnings of $0.16 per share. This is a 128.57 percent increase over earnings of $0.07 per share from the same period last year. The company reported $175.74…
- benzinga.com Anglo American Potential Bidding War; Gold Resource Q1 Results; US Acts Against Aluminum Dumping And More: Friday's Top Mining Stories Anglo American rejects BHP's $39B bid, sparking potential bidding war with Glencore. Gold Resource reports Q1 results. US imposes preliminary duties on aluminum extrusion producers. Nexa Resources…
- benzinga.com Top 5 Materials Stocks That May Implode In April As of April 3, 2024, five stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
- benzinga.com Cleveland-Cliffs Considers Bid For US Steel; Tredegar And Radius Recycling Report Financial Results And More: Friday's Top Mining Stories Top Stories for March 15, 2024: 1. Cleveland-Cliffs CEO considering lower bid for U.S. Steel backed by union, while Tredegar Corporation reports financial losses in fourth quarter. 2. Radius…
- benzinga.com Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
- benzinga.com Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLND) rose sharply during Friday’s session after the company reported…
- benzinga.com Tredegar Q4 EPS $(0.01) Down From $0.02 YoY, Sales $169.34M Down From $189.15M YoY Tredegar (NYSE:TG) reported quarterly losses of $(0.01) per share. This is a 150 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $169.34 million…
- benzinga.com Earnings Scheduled For March 15, 2024 Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.